Guven Gamze, Lohmann Ebba, Bras Jose, Gibbs J Raphael, Gurvit Hakan, Bilgic Basar, Hanagasi Hasmet, Rizzu Patrizia, Heutink Peter, Emre Murat, Erginel-Unaltuna Nihan, Just Walter, Hardy John, Singleton Andrew, Guerreiro Rita
Department of Genetics, Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey.
Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
PLoS One. 2016 Sep 15;11(9):e0162592. doi: 10.1371/journal.pone.0162592. eCollection 2016.
'Microtubule-associated protein tau' (MAPT), 'granulin' (GRN) and 'chromosome 9 open reading frame72' (C9ORF72) gene mutations are the major known genetic causes of frontotemporal dementia (FTD). Recent studies suggest that mutations in these genes may also be associated with other forms of dementia. Therefore we investigated whether MAPT, GRN and C9ORF72 gene mutations are major contributors to dementia in a random, unselected Turkish cohort of dementia patients. A combination of whole-exome sequencing, Sanger sequencing and fragment analysis/Southern blot was performed in order to identify pathogenic mutations and novel variants in these genes as well as other FTD-related genes such as the 'charged multivesicular body protein 2B' (CHMP2B), the 'FUS RNA binding protein' (FUS), the 'TAR DNA binding protein' (TARDBP), the 'sequestosome1' (SQSTM1), and the 'valosin containing protein' (VCP). We determined one pathogenic MAPT mutation (c.1906C>T, p.P636L) and one novel missense variant (c.38A>G, p.D13G). In GRN we identified a probably pathogenic TGAG deletion in the splice donor site of exon 6. Three patients were found to carry the GGGGCC expansions in the non-coding region of the C9ORF72 gene. In summary, a complete screening for mutations in MAPT, GRN and C9ORF72 genes revealed a frequency of 5.4% of pathogenic mutations in a random cohort of 93 Turkish index patients with dementia.
“微管相关蛋白tau”(MAPT)、“颗粒蛋白”(GRN)和“9号染色体开放阅读框72”(C9ORF72)基因突变是已知的额颞叶痴呆(FTD)的主要遗传病因。最近的研究表明,这些基因的突变也可能与其他形式的痴呆有关。因此,我们调查了在一个随机选取、未经过筛选的土耳其痴呆患者队列中,MAPT、GRN和C9ORF72基因突变是否是痴呆的主要促成因素。为了鉴定这些基因以及其他FTD相关基因(如“带电荷的多囊泡体蛋白2B”(CHMP2B)、“FUS RNA结合蛋白”(FUS)、“TAR DNA结合蛋白”(TARDBP)、“聚集体蛋白1”(SQSTM1)和“含缬酪肽蛋白”(VCP))中的致病突变和新变异,我们进行了全外显子组测序、桑格测序以及片段分析/ Southern印迹分析。我们确定了一个致病的MAPT突变(c.1906C>T,p.P636L)和一个新的错义变异(c.38A>G,p.D13G)。在GRN基因中,我们在第6外显子的剪接供体位点发现了一个可能致病的TGAG缺失。发现3名患者在C9ORF72基因的非编码区携带GGGGCC重复扩增。总之,对93名患有痴呆的土耳其索引患者的随机队列进行的MAPT、GRN和C9ORF72基因的全面突变筛查显示,致病突变的发生率为5.4%。